Skip to main content
Log in

Effects of Verapamil and Mibefradil on Regional Blood Flow and Function in Normal and Ischemic Myocardium

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Scholz H. Pharmacological aspects of calcium channel blockers. Cardiovasc Drugs Ther 1997;10(Suppl. 3):869–872.

    Google Scholar 

  2. Opie LH. Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc Drugs Ther 1992;6:19–24.

    Google Scholar 

  3. Heusch G. Ischemia-selectivity: A new concept of cardioprotection by calcium antagonists. Basic Res Cardiol 1994;89:2–5.

    Google Scholar 

  4. Schulz R, Post H, Jalowy A, et al. Unique cardioprotective action of the new calcium antagonist mibefradil. Circulation 1999;99:305–311.

    Google Scholar 

  5. Ross J, Jr. Mechanisms of regional ischemia and antianginal drug action during exercise. Prog Cardiovasc Dis 1989;31:455–466.

    Google Scholar 

  6. Roux S, Bühler M, Clozel J-P. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: Comparison with amlodipine. J Cardiovasc Pharmacol 1996;27:132–139.

    Google Scholar 

  7. Clozel J-P, Banken L, Osterrieder W. Effects of Ro 40–5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: Comparison with verapamil. J Cardiovasc Pharmacol 1989;14:713–721.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Behrends, M., Schulz, R. & Heusch, G. Effects of Verapamil and Mibefradil on Regional Blood Flow and Function in Normal and Ischemic Myocardium. Cardiovasc Drugs Ther 13, 275–276 (1999). https://doi.org/10.1023/A:1007760512698

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007760512698

Navigation